“✔토지노추천 【위너보증.com / 가입코드 9122】 토토사이트 ✔”的搜索结果，显示 51-60 项，共有 10354 项

1. Limited disclosure of patient information among those participating in liver study - 妙佑医疗国际

   On February 28, 2025, Mayo Clinic learned that research data containing limited Protected Health Information (PHI) related to the use of magnetic resonance ...

2. 血液科- 临床试验- 妙佑医疗国际

   ... no clinical evidence of residual (macroscopic) disease following an attempt to perform definitive treatment (including surgery, radiation and/or adjuvant or ...

3. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

4. 放射科- 临床试验- 妙佑医疗国际

   The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as measured by 6-month PFS rate, ...

5. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

6. 放射科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The primary purpose of this study is to assess the feasibility of performing lung and kidney and lung ultrasound elastography among patients ...

7. 神经科- 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to determine if adaptive rhythmic auditory stimulation (ARAS) is a safe means of improving gait; i.e., fewer ...

8. 血液科- 临床试验- 妙佑医疗国际

   ... no clinical evidence of residual (macroscopic) disease following an attempt to perform definitive treatment (including surgery, radiation and/or adjuvant or ...

9. 神经科- 临床试验- 妙佑医疗国际

   The purpose of this study is to measure target engagement in cerebrospinal fluid (CSF) and blood, and to establish the feasibility and safety of Dasatinib ...

10. 肾病和高血压 - 临床试验 - 妙佑医疗国际

    The more patients we are able to enter into the registry, the more we will be able to understand the Primary Hyperoxalurias,Dent disease, cystinuria and APRT ...